Trials / Completed
CompletedNCT02341482
A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects
A Phase 1, Open-label, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Pharmacokinetics Of Pf 04958242 In Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the current study is to characterize the pharmacokinetic (PK) profile of PF 04958242 when co administered with a strong cytochrome P450 3A4 (CYP3A4) inhibitor.
Detailed description
This study was previously posted by Pfizer, Inc. Sponsorship of the trial was transferred to Biogen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PF-04958242 | Administered as specified in the treatment arm |
| DRUG | Itraconazole | Administered as specified in the treatment arm |
Timeline
- Start date
- 2015-02-05
- Primary completion
- 2015-03-31
- Completion
- 2015-03-31
- First posted
- 2015-01-19
- Last updated
- 2020-01-09
- Results posted
- 2016-06-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02341482. Inclusion in this directory is not an endorsement.